ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma

BJU International

Volumn 110, Issue 11 B, 2012, Pages

  Kaffenberger, Samuel D ^a   Morgan, Todd M ^a   Stratton, Kelly L ^a   Boachie, Adu M ^a   Barocas, Daniel A ^a,b   Chang, Sam S ^a   Cookson, Michael S ^a   Herrell, S Duke ^a   Smith, Joseph A ^a   Clark, Peter E ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

Blood group; Nephrectomy; Renal cell carcinoma

Indexed keywords

ADULT; AGED; ANEMIA; ARTICLE; BLOOD GROUP ABO SYSTEM; BLOOD GROUP O; BLOOD TRANSFUSION; CANCER PATIENT; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEALTH STATUS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOALBUMINEMIA; KIDNEY CARCINOMA; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; OVERALL SURVIVAL; PARTIAL NEPHRECTOMY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; BLOOD; COMPARATIVE STUDY; FOLLOW UP; KAPLAN MEIER METHOD; KIDNEY TUMOR; MIDDLE AGED; MORTALITY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; UNITED STATES;

ABO BLOOD-GROUP SYSTEM; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEPHRECTOMY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; UNITED STATES;

MLCS; MLOWN;

EID: 84876445209     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11366.x     Document Type: Article

References (28)

1. HCUP Databases. Healthcare Cost and Utilization Project (HCUP). Rockville, MD : Agency for Healthcare Research and Quality, 2009. Available at: http://www.hcup-us.ahrq.gov/databases.jsp
2. Karakiewicz PI, Suardi N, Capitanio U et al. A preoperative prognostic model for patients treated with nephrectomy for renal cell carcinoma. Eur Urol 2009 ; 55 : 287-95
3. Kutikov A, Egleston BL, Wong YN, Uzzo RG. Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram. J Clin Oncol 2010 ; 28 : 311-7
4. Morgan TM, Tang D, Stratton KL et al. Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma. Eur Urol 2011 ; 59 : 923-8
5. Kosari F, Parker AS, Kube DM et al. Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness. Clin Cancer Res 2005 ; 11 : 5128-39
6. Linehan WM, Pinto PA, Bratslavsky G et al. Hereditary kidney cancer: unique opportunity for disease-based therapy. Cancer 2009 ; 115 : 2252-61
7. Aird I, Bentall HH, Roberts JA. A relationship between cancer of stomach and the ABO blood groups. Br Med J 1953 ; 1 : 799-801
8. Wolpin BM, Chan AT, Hartge P et al. ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst 2009 ; 101 : 424-31
9. Janus ZL, Bailar JC 3rd, Eisenberg H. Blood group and uterine cancer. Am J Epidemiol 1967 ; 86 : 569-78
10. Cartwright RA, Adib R, Appleyard I et al. ABO, MNSs and rhesus blood groups in bladder cancer. Br J Urol 1983 ; 55 : 377-81
11. Iodice S, Maisonneuve P, Botteri E, Sandri MT, Lowenfels AB. ABO blood group and cancer. Eur J Cancer 2010 ; 46 : 3345-50
12. Costantini M, Fassio T, Canobbio L, Landucci M, Resasco M, Boccardo F. Role of blood groups as prognostic factors in primary breast cancer. Oncology 1990 ; 47 : 308-12
13. Desai M, Brown HE. ABO blood group in relation to hypernephroma. Urology 1976 ; 8 : 596-7
14. Giannopoulos A, Kostakopoulos A, Sofras F, Kyriakidis A, Pantazopoulos D. Relation of ABO and RH blood groups with renal cell carcinoma. Acta Urol Belg 1985 ; 53 : 29-31
15. Reid ME, Mohandas N. Red blood cell blood group antigens: structure and function. S emin Hematol 2004 ; 41 : 93-117
16. Cordon-Cardo C, Lloyd KO, Finstad CL et al. Immunoanatomic distribution of blood group antigens in the human urinary tract. Influence of secretor status. Lab Invest 1986 ; 55 : 444-54
17. Newman AJ Jr, Carlton CE Jr, Johnson S. Cell surface A, B, or O(H) blood group antigens as an indicator of malignant potential in stage A bladder carcinoma. J Urol 1980 ; 124 : 27-9
18. Cordon-Cardo C, Reuter VE, Finstad CL et al. Blood group-related antigens in human kidney: modulation of Lewis determinants in renal cell carcinoma. Cancer Res 1989 ; 49 : 212-8
19. Ghazizadeh M, Kagawa S, Kurokawa K. Immunohistochemical studies of human renal cell carcinomas for ABO(H) blood group antigens, T antigen-like substance and carcinoembryonic antigen. J Urol 1985 ; 133 : 762-6
20. Hakomori S. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res 1996 ; 56 : 5309-18
21. Meany DL, Chan DW. Aberrant glycosylation associated with enzymes as cancer biomarkers. Clin Proteomics 2011 ; 8 : 7
22. Gao S, Worm J, Guldberg P et al. Genetic and epigenetic alterations of the blood group ABO gene in oral squamous cell carcinoma. Int J Cancer 2004 ; 109 : 230-7
23. Pare G, Chasman DI, Kellogg M et al. Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women. Plos Genet 2008 ; 4 : e1000118
24. Banks RE, Gearing AJ, Hemingway IK, Norfolk DR, Perren TJ, Selby PJ. Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. Br J Cancer 1993 ; 68 : 122-4
25. Gogali A, Charalabopoulos K, Zampira I et al. Soluble adhesion molecules E-cadherin, intercellular adhesion molecule-1, and E-selectin as lung cancer biomarkers. Chest 2010 ; 138 : 1173-9
26. Yamada M, Yanaba K, Takehara K, Sato S. Clinical significance of serum levels of soluble intercellular adhesion molecule-1 and soluble L-selectin in malignant melanoma. Arch Dermatol Res 2005 ; 297 : 256-60
27. Barbalic M, Dupuis J, Dehghan A et al. Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. Hum Mol Genet 2010 ; 19 : 1863-72
28. Garratty G, Glynn SA, McEntire R. ABO and Rh(D) phenotype frequencies of different racial/ethnic groups in the United States. Transfusion 2004 ; 44 : 703-6